Gastric Cancer Transcription Factors in Patient Reported Outcomes (GCTF-PRO) – Draft proposal
University of Sydney, Sydney, Australia
- Published
- Accepted
- Subject Areas
- Evidence Based Medicine, Health Policy, Translational Medicine, Statistics, Palliative Care
- Keywords
- gastric cancer, patient reported outcome, QOL, EORTC, genetics, transcription, DNA, cancer, PROM, genes
- Copyright
- © 2015 Lee
- Licence
- This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ PrePrints) and either DOI or URL of the article must be cited.
- Cite this article
- 2015. Gastric Cancer Transcription Factors in Patient Reported Outcomes (GCTF-PRO) – Draft proposal. PeerJ PrePrints 3:e1344v1 https://doi.org/10.7287/peerj.preprints.1344v1
Abstract
The GCTF-PRO seeks to examine the extent gastric cancer patients are tapping into new information particularly outside of conventional healthcare disclosures. Its significance is in assessing dimensions of QOL paradigms that frame statistical power using predictive methods. It seeks to embed evidence-based theories (perceptual and cognitive) to awareness levels in an attempt to bridge the biotechnological advances with prognostic/ diagnostic-related patient satisfactions. At present, it may complement existing GC QOL instruments and offer a novel approach on how cellular level prognoses could possibly correlate with QOL measures.
Author Comment
This is a draft proposal for a QOL measure I haven't had time to action. Any feedback would be much appreciated.